UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selumetinib plus docetaxel for KRAS -mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study

The lancet oncology, 2013, Vol.14 (1), p.38-47

2013

Volltextzugriff (PDF)

Telomere Status of Advanced Non-Small-Cell Lung Cancer Offers a Novel Promising Prognostic and Predictive Biomarker

Cancers, 2023-01, Vol.15 (1), p.290

2023

Volltextzugriff (PDF)

Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU study

Lung cancer (Amsterdam, Netherlands), 2024-10, Vol.196, p.107934, Article 107934

2024

Volltextzugriff (PDF)

Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019

Cancers, 2020-12, Vol.12 (12), p.3608

2020

Volltextzugriff (PDF)

Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)

Journal for immunotherapy of cancer, 2022-10, Vol.10 (10), p.e005636

2022

Volltextzugriff (PDF)

Oligroprogression sous nivolumab du cancer bronchique non à petites cellules métastatiques traitées par radiothérapie

Bulletin du cancer, 2023-12, Vol.110 (12), p.1234-1243

2023

Volltextzugriff (PDF)

Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study)

Lung cancer (Amsterdam, Netherlands), 2014-02, Vol.83 (2), p.182-188

2014

Volltextzugriff (PDF)

Organizing pneumonia after rituximab therapy: Two cases

Joint, bone, spine : revue du rhumatisme, 2008-05, Vol.75 (3), p.362-365

2008

Volltextzugriff (PDF)

Phase II double-blind, randomized study of selumetinib (SEL) plus docetaxel (DOC) versus DOC plus placebo as second-line treatment for advanced KRAS mutant non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.7503-7503

2012

Volltextzugriff (PDF)

Le statut télomérique dans le cancer bronchopulmonaire : un nouveau biomarqueur du pronostic et de la résistance à l’immunothérapie

Morphologie, 2019-11, Vol.103 (342), p.83-84

2019

Volltextzugriff (PDF)

Multiplex analysis of the immune environment before and after neoadjuvant durvalumab as a prognostic factor in resectable non-small cell lung cancer (NSCLC) in the IFCT-1601 IONESCO phase 2 trial

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8022-8022

2024

Volltextzugriff (PDF)

STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107508, Article 107508

2024

Volltextzugriff (PDF)

Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohort

Lung cancer (Amsterdam, Netherlands), 2020-05, Vol.143, p.36-39

2020

Volltextzugriff (PDF)

Interest of focal radiotherapy in case of oligoprogression under immunotherapy in the treatment of metastatic non-small cell lung cancer

Bulletin du cancer, 2023-12, Vol.110 (12), p.1234

2023

Volltextzugriff (PDF)

Alterations in comprehensive geriatric assessment decrease survival of elderly patients with cancer

European journal of cancer (1990), 2018-02, Vol.90, p.10-18

2018

Volltextzugriff (PDF)

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: Results from the IFCT-0802 trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7505-7505

2014

Volltextzugriff (PDF)

Pneumopathie organisée après traitement par rituximab : deux observations

Revue du rhumatisme (Ed. française : 1993), 2008-05, Vol.75 (5), p.500-503

2008

Volltextzugriff (PDF)

Alveolar hemorrhage after infliximab therapy

Joint, bone, spine : revue du rhumatisme, 2010-03, Vol.77 (2), p.189-190

2010

Volltextzugriff (PDF)

Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study

Chinese clinical oncology, 2015-12, Vol.4 (4), p.39

2015

Volltextzugriff (PDF)

Hémorragie intra-alvéolaire après traitement par infliximab

Revue du rhumatisme (Ed. française : 1993), 2010-03, Vol.77 (2), p.220-221

2010

Volltextzugriff (PDF)

Alveolar hemorrhage after infliximab therapy

Joint bone spine, 2010, Vol.77 (2), p.189-190

2010

Volltextzugriff (PDF)

Zika virus detection in urine from patients with Guillain-Barré syndrome on Martinique, January 2016

Euro surveillance : bulletin européen sur les maladies transmissibles, 2016-03, Vol.21 (9), p.30154-30154

2016

Volltextzugriff (PDF)

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment

The Lancet (British edition), 2006-04, Vol.367 (9519), p.1335-1342

2006

Volltextzugriff (PDF)

Guillain-Barré Syndrome Associated With Zika Virus Infection in Martinique in 2016: A Prospective Study

Clinical infectious diseases, 2017-11, Vol.65 (9), p.1462-1468

2017

Volltextzugriff (PDF)

Septic Shock Sera Containing Circulating Histones Induce Dendritic Cell–Regulated Necrosis in Fatal Septic Shock Patients

Critical care medicine, 2015-04, Vol.43 (4), p.e107-e116

2015

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(25)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(13)
Female
(10)
Male
(10)
Oncology
(10)
Middle Aged
(7)
Aged
(6)
Immunotherapy
(6)
Prognosis
(6)
Adult
(5)
Lung Cancer
(5)
Lung Neoplasms - Pathology
(5)
Patients
(5)
Cancer
(4)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(4)
Carcinoma, Non-Small-Cell Lung - Pathology
(4)
Life Sciences
(4)
Prospective Studies
(4)
Respiratory System
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Selumetinib plus docetaxel for KRAS -mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study

Telomere Status of Advanced Non-Small-Cell Lung Cancer Offers a Novel Promising Prognostic and Predictive Biomarker

Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU study

Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019

Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)

Oligroprogression sous nivolumab du cancer bronchique non à petites cellules métastatiques traitées par radiothérapie

Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study)

Organizing pneumonia after rituximab therapy: Two cases

Phase II double-blind, randomized study of selumetinib (SEL) plus docetaxel (DOC) versus DOC plus placebo as second-line treatment for advanced KRAS mutant non-small cell lung cancer (NSCLC)

Le statut télomérique dans le cancer bronchopulmonaire : un nouveau biomarqueur du pronostic et de la résistance à l’immunothérapie

Multiplex analysis of the immune environment before and after neoadjuvant durvalumab as a prognostic factor in resectable non-small cell lung cancer (NSCLC) in the IFCT-1601 IONESCO phase 2 trial

STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial

Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohort

Interest of focal radiotherapy in case of oligoprogression under immunotherapy in the treatment of metastatic non-small cell lung cancer

Alterations in comprehensive geriatric assessment decrease survival of elderly patients with cancer

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: Results from the IFCT-0802 trial

Pneumopathie organisée après traitement par rituximab : deux observations

Alveolar hemorrhage after infliximab therapy

Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study

Hémorragie intra-alvéolaire après traitement par infliximab

Alveolar hemorrhage after infliximab therapy

Zika virus detection in urine from patients with Guillain-Barré syndrome on Martinique, January 2016

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment

Guillain-Barré Syndrome Associated With Zika Virus Infection in Martinique in 2016: A Prospective Study

Septic Shock Sera Containing Circulating Histones Induce Dendritic Cell–Regulated Necrosis in Fatal Septic Shock Patients

Aktive Filter

Suchergebnisse filtern